XHKG
9997
Market cap1.38bUSD
Nov 11, Last price
9.20HKD
Name
Kangji Medical Holdings Ltd
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Kangji Medical Holdings Limited, together with its subsidiary companies, focuses on the entire lifecycle of advanced minimally invasive surgical instruments and their accessories, from initial design and development to manufacturing and sales, primarily serving the Chinese market. The company's extensive product range includes various single-use instruments, such as trocars, polymer ligation clips, electrocoagulation forceps, and ultrasonic scalpels, alongside other disposable hand-held devices. Complementing these are its multi-use offerings, which feature reusable trocars and forceps, among other re-sterilizable products. These specialized tools are utilized across several medical disciplines, including obstetrics and gynecology, general surgery, urology, and thoracic surgery. Kangji Medical primarily distributes its products through an established network of distributors. The company, which has its headquarters in Hangzhou, China, commenced operations in 2004.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||